7^th International Conference on Parkinson’s & Movement Disorders

November 11-12, 2019 | London, UK

Keynote

• A researcher’s perspective on Parkinson’s disease

  Rebecca Dyanne Wooten

  PDF HTML Digital File

• Glucocerebrosidase Gene Therapy for Parkinson’s disease

  Jose Luis Lanciego Perez

  PDF HTML Digital File

• Inzomelid is a CNS penetrant anti-inflammatory drug that blocks NLRP3 inflammasome activation targeted to prevent Synuclein Pathology and Dopaminergic Degeneration in Parkinson’s disease

  Matthew A Cooper

  PDF HTML Digital File

• Role of Neuromelanin in Parkinson’s disease

  Iria Carballo-Carbajal

  PDF HTML Digital File

Google Scholar citation report

Citations : 500

Journal of Neurology and Clinical Neuroscience received 500 citations as per Google Scholar report

Journal of Neurology and Clinical Neuroscience peer review process verified at publons